| Q73489981 | Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia |
| Q43061147 | Avoiding stroke during cardiac surgery |
| Q35607577 | Brain injury after adult cardiac surgery |
| Q48180030 | Can postoperative cognitive dysfunction be avoided? |
| Q33997255 | Central nervous system dysfunction after anesthesia in the geriatric patient |
| Q33833808 | Cerebral microembolization during primary total hip arthroplasty and neuropsychologic outcome: a pilot study |
| Q37608458 | Cognitive functions in patients with cerebrovascular disease: potential impact of revascularization |
| Q35172511 | Coronary-artery bypass surgery and the brain: persisting concerns |
| Q35084302 | Effect of piracetam on the cognitive performance of patients undergoing coronary bypass surgery: A meta-analysis |
| Q48498386 | Effect on the brain of two techniques of myocardial protection |
| Q50650998 | Evaluation of an alternative S100b assay for use in cardiac surgery: relationship with microemboli and neuropsychological outcome. |
| Q35854268 | Examining the effects of adjuvant chemotherapy on cognition and the impact of any cognitive impairment on quality of life in colorectal cancer patients: study protocol |
| Q24248015 | Excitatory amino acid antagonists for acute stroke |
| Q30473667 | In vivo therapeutic gas delivery for neuroprotection with echogenic liposomes. |
| Q37476969 | Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery |
| Q44332173 | Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies |
| Q37755882 | Is there a future for neuroprotective agents in cardiac surgery? |
| Q59134386 | Is xenon a future neuroprotectant? |
| Q36188715 | KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders. |
| Q44535353 | Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study. |
| Q37441140 | Lignocaine: neuro-protective or wishful thinking? |
| Q34056910 | Measurement of post-operative cognitive dysfunction after cardiac surgery: a systematic review |
| Q33667442 | Neurological complications of cardiac surgery: the need for new paradigms in prevention and treatment |
| Q35829961 | Neuronal death enhanced by N-methyl-D-aspartate antagonists |
| Q90150755 | Neuroprotection against stroke and encephalopathy after cardiac surgery |
| Q40123556 | Neuroprotection and the ischemic cascade |
| Q36902871 | Neuroprotection during cardiac surgery |
| Q40104270 | Neuroprotection during cardiac surgery |
| Q35581372 | Neuroprotection during cardiac surgery: a randomised trial of a platelet activating factor antagonist |
| Q34636341 | Neuroprotection during cardiac surgery: strategies to reduce cognitive decline |
| Q35561186 | Neuroprotection in cardiac surgery |
| Q33502211 | Neuropsychological sequelae of carotid angioplasty with stent placement: correlation with ischemic lesions in diffusion weighted imaging |
| Q48192551 | Neuropsychometric outcome following aortic arch surgery: a prospective randomized trial of retrograde cerebral perfusion |
| Q51899084 | Patients reported health-related quality of life five years post coronary artery bypass graft surgery--a methodological study. |
| Q36375846 | Pharmacologic neuroprotection: the search continues. |
| Q44163551 | Pharmacological agents as cerebral protectants during deep hypothermic circulatory arrest in adult thoracic aortic surgery. A survey of current practice |
| Q36771142 | Pharmacological neuroprotection during cardiac surgery |
| Q48650551 | Post-ischemic helium provides neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia |
| Q57362010 | Posttraumatic epilepsy: The endophenotypes of a human model of epileptogenesis |
| Q30968894 | Prophylactic Edaravone Prevents Transient Hypoxic-Ischemic Brain Injury: Implications for Perioperative Neuroprotection |
| Q45018006 | Propofol offers no advantage over isoflurane anesthesia for cerebral protection during cardiopulmonary bypass: a preliminary study of S-100beta protein levels |
| Q37032255 | Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery |
| Q34074824 | Remacemide: current status and clinical applications |
| Q26780541 | Risk Factors Associated with Cognitive Decline after Cardiac Surgery: A Systematic Review |
| Q73674062 | The role of apolipoprotein E in cognitive decline after cardiac operation |
| Q48360729 | The use of Z scores in assessing neuropsychological change after cardiac operations |
| Q33887012 | Why do neuroprotective drugs work in animals but not humans? |
| Q40428767 | Xenon Blocks Neuronal Injury Associated with Decompression |